Biohealth and rapid diagnostics company will create 46 high-paying jobs in Wisconsin over the next three years
MADISON, Wis. (June 1, 2026) — Abingdon Health USA Inc., an international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech products, will expand its operations in Madison, Wisconsin, with an investment of more than $1.8 million. The project is expected to create 46 high-paying jobs over the next three years and further strengthen Wisconsin’s growing biohealth and biotechnology sector.
Abingdon Health USA is a wholly owned subsidiary of Abingdon Health plc, a publicly listed company on the London Stock Exchange. The company established its Madison operation in 2024 to create a U.S.-based contract development and manufacturing organization, or CDMO, to serve customers across the country.
The expansion will support the development of a state-of-the-art manufacturing facility in Madison designed for rapid scale-up as market demand increases. The project will create a fully integrated lateral flow diagnostic CDMO operation in Wisconsin, mirroring Abingdon’s established capabilities in the United Kingdom and providing customers with greater flexibility in bringing diagnostic products to market.
The Wisconsin Economic Development Corporation is supporting the project by authorizing up to $370,000 in performance-based state income tax credits. The final amount of tax credits Abingdon Health USA receives will depend on the number of jobs created and the total capital investment made during the project period.
“Abingdon’s decision to locate in Wisconsin and continue to grow here reflects the strength of our state’s leadership in the field of biohealth and biotechnology, our outstanding research institutions, and our highly trained workforce,” said John W. Miller, secretary and CEO of WEDC, the state’s leading economic development organization. “WEDC is proud to partner with Abingdon as they open this next chapter.”
Abingdon Health USA’s expansion at University Research Park in Madison will create additional skilled positions as the company continues to meet rising customer demand throughout the United States.
“We are grateful for this award from the Wisconsin Economic Development Corporation, which serves as a welcome endorsement of our commitment and investment in Wisconsin and our positioning in the U.S. market,” said Chris Yates, president of Abingdon Health USA. “These tax credits will support our expansion at University Research Park in Madison, including the creation of additional skilled roles as Abingdon Health USA continues to grow to meet customer demand across the United States.”
The company’s growth adds to Wisconsin’s expanding roster of global biohealth and biotechnology firms. In 2024, the U.S. Economic Development Administration designated Wisconsin as a Regional Technology Hub for biohealth and personalized medicine, allocating approximately $49 million to support greater collaboration and innovation among key industry partners in the state.
Over the next decade, the Wisconsin BioHealth Tech Hub is projected to create more than 30,000 direct jobs and 111,000 indirect jobs across Wisconsin.
Abingdon Health USA’s expansion reflects continued momentum in Wisconsin’s biohealth sector, where strong research institutions, a skilled workforce and coordinated economic development support are helping companies scale advanced medical technologies and diagnostic manufacturing operations.
About the Wisconsin Economic Development Corporation
The Wisconsin Economic Development Corporation leads economic development efforts for the state by advancing and maximizing opportunities for businesses, communities and people to thrive in a globally competitive environment. Working with more than 600 regional and local partners, WEDC develops and delivers solutions through a responsive and coordinated economic development network. For more information, visit wedc.org.
